103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB4628

 

Introduced 1/31/2024, by Rep. Jawaharial Williams

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/208  from Ch. 56 1/2, par. 1208

    Amends the Illinois Controlled Substances Act. Schedules Tianeptine as a Schedule III controlled substance.


LRB103 35592 RLC 65665 b

 

 

A BILL FOR

 

HB4628LRB103 35592 RLC 65665 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 208 as follows:
 
6    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)
7    Sec. 208. (a) The controlled substances listed in this
8Section are included in Schedule III.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any material, compound, mixture, or
11preparation which contains any quantity of the following
12substances having a stimulant effect on the central nervous
13system, including its salts, isomers (whether optical
14position, or geometric), and salts of such isomers whenever
15the existence of such salts, isomers, and salts of isomers is
16possible within the specific chemical designation;
17        (1) Those compounds, mixtures, or preparations in
18    dosage unit form containing any stimulant substances
19    listed in Schedule II which compounds, mixtures, or
20    preparations were listed on August 25, 1971, as excepted
21    compounds under Title 21, Code of Federal Regulations,
22    Section 308.32, and any other drug of the quantitative
23    composition shown in that list for those drugs or which is

 

 

HB4628- 2 -LRB103 35592 RLC 65665 b

1    the same except that it contains a lesser quantity of
2    controlled substances;
3        (2) Benzphetamine;
4        (3) Chlorphentermine;
5        (4) Clortermine;
6        (5) Phendimetrazine; .
7        (6) Tianeptine.
8    (c) Unless specifically excepted or unless listed in
9another schedule, any material, compound, mixture, or
10preparation which contains any quantity of the following
11substances having a potential for abuse associated with a
12depressant effect on the central nervous system:
13        (1) Any compound, mixture, or preparation containing
14    amobarbital, secobarbital, pentobarbital or any salt
15    thereof and one or more other active medicinal ingredients
16    which are not listed in any schedule;
17        (2) Any suppository dosage form containing
18    amobarbital, secobarbital, pentobarbital or any salt of
19    any of these drugs and approved by the Federal Food and
20    Drug Administration for marketing only as a suppository;
21        (3) Any substance which contains any quantity of a
22    derivative of barbituric acid, or any salt thereof:
23        (3.1) Aprobarbital;
24        (3.2) Butabarbital (secbutabarbital);
25        (3.3) Butalbital;
26        (3.4) Butobarbital (butethal);

 

 

HB4628- 3 -LRB103 35592 RLC 65665 b

1        (4) Chlorhexadol;
2        (5) Methyprylon;
3        (6) Sulfondiethylmethane;
4        (7) Sulfonethylmethane;
5        (8) Sulfonmethane;
6        (9) Lysergic acid;
7        (10) Lysergic acid amide;
8        (10.1) Tiletamine or zolazepam or both, or any salt of
9    either of them.
10    Some trade or other names for a tiletamine-zolazepam
11    combination product: Telazol.
12    Some trade or other names for Tiletamine:
13    2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
14    Some trade or other names for zolazepam:
15    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
16    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
17        (11) Any material, compound, mixture or preparation
18    containing not more than 12.5 milligrams of pentazocine or
19    any of its salts, per 325 milligrams of aspirin;
20        (12) Any material, compound, mixture or preparation
21    containing not more than 12.5 milligrams of pentazocine or
22    any of its salts, per 325 milligrams of acetaminophen;
23        (13) Any material, compound, mixture or preparation
24    containing not more than 50 milligrams of pentazocine or
25    any of its salts plus naloxone HCl USP 0.5 milligrams, per
26    dosage unit;

 

 

HB4628- 4 -LRB103 35592 RLC 65665 b

1        (14) Ketamine;
2        (15) Thiopental.
3    (d) Nalorphine.
4    (d.5) Buprenorphine.
5    (e) Unless specifically excepted or unless listed in
6another schedule, any material, compound, mixture, or
7preparation containing limited quantities of any of the
8following narcotic drugs, or their salts calculated as the
9free anhydrous base or alkaloid, as set forth below:
10        (1) not more than 1.8 grams of codeine per 100
11    milliliters or not more than 90 milligrams per dosage
12    unit, with an equal or greater quantity of an isoquinoline
13    alkaloid of opium;
14        (2) not more than 1.8 grams of codeine per 100
15    milliliters or not more than 90 milligrams per dosage
16    unit, with one or more active non-narcotic ingredients in
17    recognized therapeutic amounts;
18        (3) (blank);
19        (4) (blank);
20        (5) not more than 1.8 grams of dihydrocodeine per 100
21    milliliters or not more than 90 milligrams per dosage
22    unit, with one or more active, non-narcotic ingredients in
23    recognized therapeutic amounts;
24        (6) not more than 300 milligrams of ethylmorphine per
25    100 milliliters or not more than 15 milligrams per dosage
26    unit, with one or more active, non-narcotic ingredients in

 

 

HB4628- 5 -LRB103 35592 RLC 65665 b

1    recognized therapeutic amounts;
2        (7) not more than 500 milligrams of opium per 100
3    milliliters or per 100 grams, or not more than 25
4    milligrams per dosage unit, with one or more active,
5    non-narcotic ingredients in recognized therapeutic
6    amounts;
7        (8) not more than 50 milligrams of morphine per 100
8    milliliters or per 100 grams with one or more active,
9    non-narcotic ingredients in recognized therapeutic
10    amounts.
11    (f) Anabolic steroids, except the following anabolic
12steroids that are exempt:
13        (1) Androgyn L.A.;
14        (2) Andro-Estro 90-4;
15        (3) depANDROGYN;
16        (4) DEPO-T.E.;
17        (5) depTESTROGEN;
18        (6) Duomone;
19        (7) DURATESTRIN;
20        (8) DUO-SPAN II;
21        (9) Estratest;
22        (10) Estratest H.S.;
23        (11) PAN ESTRA TEST;
24        (12) Premarin with Methyltestosterone;
25        (13) TEST-ESTRO Cypionates;
26        (14) Testosterone Cyp 50 Estradiol Cyp 2;

 

 

HB4628- 6 -LRB103 35592 RLC 65665 b

1        (15) Testosterone Cypionate-Estradiol Cypionate
2    injection; and
3        (16) Testosterone Enanthate-Estradiol Valerate
4    injection.
5    (g) Hallucinogenic substances.
6        (1) Dronabinol (synthetic) in sesame oil and
7    encapsulated in a soft gelatin capsule in a U.S. Food and
8    Drug Administration approved product. Some other names for
9    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
10    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or
11    (-)-delta-9-(trans)-tetrahydrocannabinol.
12        (2) (Reserved).
13    (h) The Department may except by rule any compound,
14mixture, or preparation containing any stimulant or depressant
15substance listed in subsection (b) from the application of all
16or any part of this Act if the compound, mixture, or
17preparation contains one or more active medicinal ingredients
18not having a stimulant or depressant effect on the central
19nervous system, and if the admixtures are included therein in
20combinations, quantity, proportion, or concentration that
21vitiate the potential for abuse of the substances which have a
22stimulant or depressant effect on the central nervous system.
23(Source: P.A. 100-368, eff. 1-1-18.)